Goldman Sachs Group Inc Ionis Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 235,710 shares of IONS stock, worth $8.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
235,710
Previous 328,305 28.2%
Holding current value
$8.5 Million
Previous $15.6 Million 39.66%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$40.06 - $51.86 $3.71 Million - $4.8 Million
-92,595 Reduced 28.2%
235,710 $9.44 Million
Q2 2024

Aug 13, 2024
BUY
$36.45 - $47.7 $4.66 Million - $6.1 Million
127,925 Added 63.84%
328,305 $15.6 Million
Q1 2024

May 15, 2024
SELL
$42.03 - $53.55 $7.61 Million - $9.69 Million
-181,002 Reduced 47.46%
200,380 $8.69 Million
Q4 2023

Feb 13, 2024
BUY
$43.39 - $51.63 $1.89 Million - $2.25 Million
43,555 Added 12.89%
381,382 $19.3 Million
Q3 2023

May 14, 2024
SELL
$38.5 - $47.13 $1.68 Million - $2.05 Million
-43,555 Reduced 11.42%
337,827 $15.3 Million
Q3 2023

Nov 14, 2023
BUY
$38.5 - $47.13 $5.75 Million - $7.04 Million
149,455 Added 79.34%
337,827 $15.3 Million
Q2 2023

May 14, 2024
SELL
$34.73 - $43.33 $8.12 Million - $10.1 Million
-233,726 Reduced 55.37%
188,372 $7.73 Million
Q2 2023

Aug 14, 2023
SELL
$34.73 - $43.33 $8.12 Million - $10.1 Million
-233,726 Reduced 55.37%
188,372 $7.73 Million
Q1 2023

May 14, 2024
SELL
$33.58 - $41.2 $16.8 Million - $20.6 Million
-500,313 Reduced 54.24%
422,098 $15.1 Million
Q1 2023

May 11, 2023
SELL
$33.58 - $41.2 $16.8 Million - $20.6 Million
-500,313 Reduced 54.24%
422,098 $15.1 Million
Q4 2022

May 14, 2024
SELL
$37.12 - $46.52 $13.7 Million - $17.1 Million
-368,154 Reduced 28.53%
922,411 $34.8 Million
Q4 2022

Feb 13, 2023
SELL
$37.12 - $46.52 $13.7 Million - $17.1 Million
-368,154 Reduced 28.53%
922,411 $34.8 Million
Q3 2022

May 14, 2024
BUY
$36.54 - $48.66 $9.09 Million - $12.1 Million
248,741 Added 23.88%
1,290,565 $57.1 Million
Q3 2022

Nov 10, 2022
BUY
$36.54 - $48.66 $9.09 Million - $12.1 Million
248,741 Added 23.88%
1,290,565 $57.1 Million
Q2 2022

May 14, 2024
BUY
$31.71 - $43.0 $20.9 Million - $28.4 Million
660,442 Added 173.17%
1,041,824 $38.6 Million
Q2 2022

Aug 15, 2022
BUY
$31.71 - $43.0 $2.77 Million - $3.76 Million
87,498 Added 9.17%
1,041,824 $38.6 Million
Q1 2022

May 16, 2022
BUY
$29.88 - $37.04 $10.9 Million - $13.5 Million
365,028 Added 61.94%
954,326 $35.3 Million
Q4 2021

Feb 14, 2022
SELL
$25.61 - $35.1 $321,098 - $440,083
-12,538 Reduced 2.08%
589,298 $17.9 Million
Q3 2021

Nov 10, 2021
BUY
$33.54 - $40.55 $20.2 Million - $24.4 Million
601,836 New
601,836 $20.2 Million

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.12B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email